New hope for sarcoma: Nano-Chemo combo targets tough tumors
NCT ID NCT07359053
First seen Jan 25, 2026 · Last updated May 24, 2026 · Updated 18 times
Summary
This study tests a new drug combination for people with advanced bone or soft tissue sarcoma that has worsened after standard treatment. The combo includes a nano-form of chemotherapy and targeted drugs chosen by tumor type. The goal is to shrink tumors and reduce side effects. About 46 people will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Sixth Peolple'S Hospital
RECRUITINGShanghai, CH, 200233, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.